I thought I would share the Friends of Generex and
Post# of 36536
Monday, a letter went via email to Joe, Generex and NuGenerex, many management team members, board of director members and Todd Falls in IR.
The letter included a request for an investor update at a minimum including:
1. An update on the status of the “Complete Vaccine” IND and the plan for human trials following its approval,
2. The status and updated plan for NGIO's S-1 registration, IPO/listing on Nasdaq,
3. The funding status and updated plan for the Excellagen rollout,
4. The operational status of NuGenHealth and the forecast to achieve 3500-5000 patients near term. Mr. Kumar stated “we are going to be kicking off this RPM initiative very soon, just a matter of days, if not hours”
There were other things in the letter as well but these are the things the majority of members were interested to know. We asked for an update by September 17th.